Neuronetics, Inc.
STIM
$1.94
$0.2414.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.01% | -2.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.01% | -2.13% | |||
| Cost of Revenue | -2.56% | -0.79% | |||
| Gross Profit | 29.20% | -3.66% | |||
| SG&A Expenses | 9.40% | -4.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.04% | -3.35% | |||
| Operating Income | 36.58% | 9.15% | |||
| Income Before Tax | 23.35% | 4.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.35% | 4.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -86.52% | 226.69% | |||
| Net Income | 20.86% | 10.62% | |||
| EBIT | 36.58% | 9.15% | |||
| EBITDA | 38.83% | 10.09% | |||
| EPS Basic | 22.54% | 12.10% | |||
| Normalized Basic EPS | 25.37% | 15.64% | |||
| EPS Diluted | 22.54% | 12.10% | |||
| Normalized Diluted EPS | 25.37% | 15.64% | |||
| Average Basic Shares Outstanding | 2.15% | 1.71% | |||
| Average Diluted Shares Outstanding | 2.15% | 1.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||